Download Programme
Time Stage 1 Stage 2 Stage 3
0730 – 0900 Registration
0900 – 0930 Opening Ceremony
0930 – 1000 Keynote / Plenary 1: COVID-19
Prof Cao Bin, China
1000 – 1030 Keynote / Plenary 2: Advances in Influenza Therapeutics
Prof Frederick Hayden, United States of America
1030 – 1115 Coffee/Tea break / Exhibition / E-Posters viewing
1115 – 1315 Concurrent Symposia 1
Rapid Diagnostics
Chairs: TBA
Concurrent Symposia 2
Hot Topics in Microbiology
Chairs: TBA
Concurrent Symposia 3
MERS CoV, Avian Influenza and Other Respiratory Viruses
Chairs: TBA
From Answers in Days to Answers in Minutes
Prof Robin Patel, United States of America
Utility of Typing Carbapenemases
Prof David Paterson, Australia
Emerging Adenovirus Threats: Vaccine and Antiviral Interventions
Prof Gregory Gray, United States of America
Rapid Diagnosis for Bacterial Resistance
Prof Yohei Doi, Japan
Advances in Laboratory Mycology
Prof Arunaloke Chakrabarti, India
Novel Influenza Viruses
Prof Kanta Subbarao, Australia
Rapid Diagnosis: Where Engineering meets Infectious Diseases
Prof Jackie Y. Ying, Singapore
What is the Role of Classical Virology?
Prof Malik Peiris, Hong Kong SAR
Community MERS CoV: Clinical Aspects and Diagnosis
Prof Ziad Memish, Saudi Arabia
RABBIT: Randomised Trial of Rapid Diagnosis in Bacteraemia
Dr Shawn Vasoo, Singapore
Topic title coming soon!
Prof Andreas Voss, Netherlands
Nosocomial MERS CoV and Hospital Response
Prof Doo Ryeon Chung, Republic of Korea
1315 – 1415 Effective management of cSSTI –
bringing the focus back to the patient
Session Chair: TBA
Immunosenescence and the new recombinant zoster vaccine in the prevention of shingles
Dr Asok Kurup, Singapore
Chair: Dr James Sim Heng Chiak, Singapore
Current Trends in Superinfections in COVID 19 patients and Role of Microbiology – the
Indian experience
Dr Aruna Poojary, India
1415 – 1615 Concurrent Symposia 4
Hot Topics in Infection Control
Chairs: TBA
Concurrent Symposia 5
One Health In Infectious Diseases
Chairs: TBA
Concurrent Symposia 6
Transplant Infectious Diseases
Chairs: TBA
1415 – 1445 WHO Infection Prevention and Control
Prof Wing Hong Seto, Hong Kong SAR
Why “One Health” is critical for Public Health
Prof Malik Peiris, Hong Kong SAR
Role of Prophylaxis in the Era of AMR
Prof Tan Ban Hock , Singapore
1445 – 1515 Myths in Infection Prevention and Control
Prof Anucha Apisarnthanarak, Thailand
One Health AMR And Human Health
A/Prof Direk Limmathurotsakul, Thailand
Antifungal Stewardship
Prof Monica Slavin, Australia
1315 – 1345 Evidence based MRSA Control
Prof Yee Chun Chen, Taiwan
One Health AMR in the Environment
A/Prof Karina Gin, Singapore
Parasitology in Transplantation
A/Prof Siriorn Watchanaranan, Thailand
1545 – 1615 Update in Sterilisation
A/Prof Ling Moi Lin, Singapore
Mitigating Future Pandemics: New Threats and Strategies to Consider
Prof Gregory Gray, United States of America
Viral Hepatitis In Transplantation
Prof Vincent Cheng, Hong Kong SAR
1615 – 1645
Keynote / Plenary 3: Innovation in Antimicrobial Stewardship
Prof Alison Holmes, United Kingdom
1645 – 1730 Coffee/Tea break / Exhibition / E-Posters viewing
1730 – 1800
Keynote / Plenary 4: Bat Viruses and the Next Outbreak
Prof Linfa Wang, Singapore
1800 – 1930 Public Health Response on COVID
Chairs: TBA
Interactive Case-Based Panel Discussion on Managing CMV In The High-Risk Transplant Recipient
Paediatric ID
Chairs: TBA
1800 – 1830 Public Health Response in Singapore
A/Prof Vernon Lee, Singapore
Define the transplant recipient at high-risk of CMV infection and discuss the unmet needs and challenges in the management of CMV infection with patient cases
Prof Tan Ban Hock, Singapore
Syndromic Testing
Prof Cheng Hsun Chiu, Taiwan
1830 – 1900 Public Health Response in Taiwan
Dr Yi-Chun (Philip) Lo, Taiwan
1900 – 1930 Public Health Response in New Zealand
Speaker coming soon!
Explore investigational CMV infection management options and emerging clinical data
Dr Joe Sasadeusz, Australia
Panel Discussion
Hand Food And Mouth Diseases
Dr Mong How Ooi, Malaysia
1930 – 2000
Chair: A/Prof Helen Oh, Singapore
Evolutional and emerging issues for optimizing invasive mould infection management in Asia
Prof Charles Feldman, South Africa

2000 – 2030
TIME Stage 1 Stage 2 Stage 3
0730 – 0830 Registration
0830 – 0900
Current status of ESBL – producing bacterial infections
Chair: Dr Hiroki Ohge, Japan
Dr Hiroshige Mikamo, Japan
Dr Katsunori Yanagihara, Japan
by Japanese Society for Chemotherapy
Virtual Meet the Experts
The development and clinical validation of MiRXES Fortitude RT-PCR test kit for COVID-19 pandemic in Singapore and Philippines
Go! Developing Fortitude v2.1, an RT-PCR test for SARS-CoV-2’
Adj. Assoc Prof Timothy Mark Sebastian Barkham, Singapore
Challenges and Strategies for Conducting Clinical Validation of MiRXES Fortitude Kit 2.1 COVID-19 RT-PCR Test: Experiences from Resource Limited Settings
Prof. Pia Marie S.P. Albano, Philippines

0900 – 09300
0930 – 1000 Keynote / Plenary 5: Assessing the Value of New Diagnostics
Prof Robin Patel, United States of America
1000 – 1030 Keynote / Plenary 6: The Promise of MRNA Vaccines
Speaker coming soon!
1030 – 1115 Coffee/Tea break / Exhibition / E-Posters viewing
1115 – 1315 Concurrent Symposia 7
Clinical Implications of Microbiome
Chairs: TBA
Concurrent Symposia 8
Human Immunodeficiency Virus
Chairs: TBA
Concurrent Symposia 9
Chairs: TBA
1115 – 1145 Fungal Microbiome In Lung Diseases
Dr Sanjay Chotirmall, Singapore
Viral Hepatitis Co-Infections
Prof Sharon Lewin, Australia
New Risk Factors for Invasive Aspergillosis
Prof Monica Slavin, Australia
1145 – 1215 Implications of Environmental Microbiome
A/Prof Niranjan Nagarajan, Singapore
Pre-Exposure Prophylaxis HIV
Prof Andrew Grulich, Australia
Pre-Emptive Antifungal in Febrile Neutropenia
Prof Yee Chun Chen, Taiwan
1215 – 1245 Utility of Metagenomics in Clinical Infectious Diseases
Prof Siew Chien Ng, Hong Kong SAR
Prof Kiat Ruxrungtham, Thailand
Candida Auris
Prof Arunaloke Chakrabarthi, India
1245 – 1315 Next Generation Sequencing: First Diagnostic One-stop Shop in Clinical Microbiology
Prof John Rossen, Netherlands
HIV Decriminalisation
Prof Adeeba Kamarulzaman, Malaysia
Updates on Fungal Diagnostics
Dr Tan Yen Ee, Singapore
1315 – 1415 Evolutional and emerging issues for optimizing invasive mold infection management in Asia
Chair: TBA
Satellite Symposium
Chair: TBA
Satellite Symposium
Chair: TBA
1315 – 1345
1345 – 1415
1415 – 1615 Concurrent Symposia 10
Hot Topics in Antimicrobial Stewardship
Chair: TBA
Concurrent Symposia 11
Chair: TBA
Concurrent Symposia 12
Vector Borne Infections
Chair: TBA
1415 – 1445 Implementation Barriers in Antimicrobial Stewardship in the USA
Dr Arjun Srinivasan, United States of America
Plasmodium Vivax
A/Prof Yeo Tsin Wen, Singapore
Ticks and Fleas
Dr MacKenzie L. Kwak, Singapore
1445 – 1515 Antimicrobial Stewardship in Paediatrics
Prof Cheng-Hsun Chiu, Taiwan
Plasmodium Knowlesi
Dr Timothy William, Malaysia
Chikungunya and Zika
A/Prof Lisa Ng, Singapore
1515 – 1545 Does Antimicrobial Stewardship Work?
Prof Anucha Apisarnthanarak, Thailand
Immune Response and Malaria
Prof Laurent Renia, Singapore
Prof Eng Eong Ooi, Singapore
1545 – 1615 Advancing the Integration Antimicrobial Stewardship and Infection Prevention
Prof Alison Holmes, United Kingdom
Drug Resistance and Malaria
Prof Nicholas Day, Thailand
Arboviruses in Asia
Dr Sherry Moi, Japan
1615 – 1700 Coffee/Tea break / Exhibition / E-Posters viewing
1700 – 1730 Keynote / Plenary 7: Infections in Immunocompromised Hosts
Prof Tan Ban Hock,Singapore
1730 – 1800 Keynote / Plenary 8 HIV Cure: Are We Any Nearer?
Prof Sharon Lewin, Australia
1800 – 1900 Oral Presentation 1
Chairs: TBA
Viral Hepatitis
Chair: TBA
Hepatitis B Cure
Prof Seng Gee Lim, Singapore
Hepatitis C Elimination
Prof Margaret Hellard, Australia
1900 – 2000 COVID Symposium: COVID 19 Treatment
Chairs: TBA
1900 – 1930 Topic title coming soon!
Prof Peter Horby, United Kingdom
1930 – 2000 Treatment of Patients with COVID-19
Dr H. Clifford Lane, United States of America
TIME Stage 1 Stage 2 Stage 3
0730 – 0830 Registration
Oral Presentation 2
Chairs: TBA
COVID Symposium: Immune Response to COVID
Chairs: TBA
Management of Covid-19 in Japan
Chair: TBA
0830 – 0900 Understanding Infection and Immunity of SARS-CoV-2: from Diagnostics to Therapies
Prof Lisa Ng, Singapore
Control of 2020 coronavirus pandemic (Including Antigen Testing)
Dr Satoshi Takahashi, Japan
0900 – 0930 SARS-CoV-2 specific T cells: protection from infection or disease?
Prof Antonio Bertoletti, Singapore
Treatment for Covid-19 (Including Favipiravir)
Dr Hiroyuki Kunishima, Japan
0930 – 1000 Keynote / Plenary 9: Global And Local Challenges in AMR
Prof Ramanan Laxminarayan, United States of America
1000 – 1030 Keynote / Plenary 10: New Antibiotics
Prof David Paterson, Australia
1030 – 1115 Coffee/Tea break / Exhibition / E-Posters viewing
1115 – 1315 Concurrent Symposia 13
AMR in Human Health
Concurrent Symposia 14
Tuberculosis and Mycobacteria
Concurrent Symposia 15
Therapeutic Drug Monitoring / PK PD
1115 – 1145 Treatment of XDR And PDR Gram Negative Bacteria
Prof Po Ren Hsueh, Taiwan
Corticosteroid in Tuberculosis
Prof Guy Thwaites, Vietnam
Optimising PK PD For Antimalarials
Prof Nicholas Day, Thailand
1145 – 1215 Control of XDR Acinetobacter Baumannii
Prof Vincent Cheng, Hong Kong SAR
Immunomodulation in Tuberculosis
Dr Catherine Ong, Singapore
TDM in Antifungals
Prof Deborah JE Marriott, Australia
1215 – 1245 Role of Surveillance in Combating AMR
Prof Jae Hoon Song, Republic of Korea
MDR TB in Singapore
A/Prof Cynthia Chee, Singapore
TDM in Beta-Lactams
Prof Jason Roberts, Australia
1245 – 1315 Epidemiology and Transmission of Carbapenem-Resistant Hypervirulent Klebsiella Pneumoniae
Prof Hui Wang, China
Non-Tuberculous Mycobacteria In Asia
Prof Po Ren Hsueh, Taiwan
TDM in Sepsis
Prof Jeffrey Lipman, Australia
1315 – 1415 The glimpse of glistening solutions for MDRO infections in Asia
Chair: Dr. Wong Chen Seong, Singapore
Inflammation in HIV: More Than Meets the Eyes
Dr. Sergio Serrano-Villar

Chair: Prof Glenda Gray, South Africa
Optimizing COVID-19 Vaccination in Asia Pacific
Prof Anna Ong-Lim, Philippines
Prof Young June Choe, Korea

1315 – 1345
1345 – 1415
1415 – 1615 Concurrent Symposia 16
Utility of Genomic Sequencing
Concurrent Symposia 17
SARS COV2 in Singapore
Concurrent Symposia 18
1415 – 1445 Genomic Sequencing in Bacteria
Prof Yohei Doi, Japan
Role of National Centre in Emerging Infections
Prof Leo Yee Sin, Singapore
Novel Strategies Influenza Vaccination
Dr Barnaby Young, Singapore
1445 – 1515 Genomic Sequencing in MERS CoV
Dr Waleed Abdurhman Al-Jabr, Saudi Arabia
How SARS COV2 evolves
Dr Sebastian Maurer-Stroh, Singapore
Vaccines for Flaviviruses
Prof Annelies Wilder-Smith, United Kingdom
1515 – 1545 Genomic Sequencing in Infection Control
Prof John Rossen, Netherlands
Infection Control in SARS COV2
Dr Kalisvar Marimuthu, Singapore
Rotavirus Vaccine Rollout
Prof Gagandeep Kang, India
1545 – 1615 Advances in Genomic Sequencing
A/Prof Niranjan Nagarajan, Singapore
COVID19 Diagnostics
Dr Shawn Vasoo, Singapore
Poliomyelitis Endgame
Prof David Heymann, United Kingdom
1615 – 1645 Coffee/Tea break / Exhibition / E-Posters viewing
1645 – 1715
Closing Ceremony
Presentation Of Awards:
1. Best Oral And Poster Presenters, 2. SIDS Institut Mérieux Young Investigator Award

Programme is updated as of 14 October 2021
The programme may be subject to change without prior notice.
*Speaker pending confirmation